Prognostic value of subtype changes after neoadjuvant chemotherapy in primary breast cancer

被引：0
|
作者：
Matsumoto, Akiko [1 ]
Umemoto, Yasuko [1 ]
Yoshikawa, Mio [1 ]
Jinno, Hiromitsu [1 ]
机构：
[1] Teikyo Univ, Sch Med, Dept Surg, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O2 - 8 -5
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Patterns of Response to Neoadjuvant Chemotherapy by Breast Cancer Subtype
    Pastorello, Ricardo
    Grossmith, Samantha
    Choi, Jungeun
    Laws, Alison
    Golshan, Mehra
    Mittendorf, Elizabeth
    Schnitt, Stuart
    King, Tari
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 232 - 233
  • [22] Prognostic Value of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Advanced Stage Breast Cancer
    Suta, T.
    Mutuleanu, M.
    Marian, S.
    Gherghe, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S489 - S489
  • [23] The prognostic value of FDG response after two cycles of neoadjuvant chemotherapy in triple negative breast cancer
    Groheux, D.
    Hindie, E.
    Giacchetti, S.
    Delord, M.
    Hamy, A.
    de Roquancourt, A.
    Vercellino, L.
    Berenger, N.
    Marty, M.
    Espie, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S217 - S217
  • [24] Prognostic Value at 4 Years of FDG PET, after the First Course of Neoadjuvant Chemotherapy in Breast Cancer
    Humbert, O.
    Berriolo-Riedinger, A.
    Arnoud, L.
    Coudert, B.
    Toubeau, M.
    Dygai-Cochet, I.
    Cochet, A.
    Mayer, F.
    Fumoleau, P.
    Brunotte, F.
    CANCER RESEARCH, 2010, 70
  • [25] Prognostic value of receptor conversion after neoadjuvant chemotherapy in breast cancer patients: a prospective observational study
    Jin, Xi
    Jiang, Yi-Zhou
    Chen, Sheng
    Yu, Ke-Da
    Shao, Zhi-Ming
    Di, Gen-Hong
    ONCOTARGET, 2015, 6 (11) : 9600 - 9611
  • [26] Prognostic value of pathologic complete response and the alteration of breast cancer immunohistochemical biomarkers after neoadjuvant chemotherapy
    Shuai, Yanjie
    Ma, Li
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (01) : 29 - 33
  • [27] The Prognostic Value of Lymph Node Involvement after Neoadjuvant Chemotherapy Is Different among Breast Cancer Subtypes
    Laot, Lucie
    Laas, Enora
    Girard, Noemie
    Dumas, Elise
    Daoud, Eric
    Grandal, Beatriz
    Pierga, Jean-Yves
    Coussy, Florence
    Kirova, Youlia
    El-Alam, Elsy
    Bataillon, Guillaume
    Lae, Marick
    Llouquet, Florence
    Reyal, Fabien
    Hamy, Anne-Sophie
    CANCERS, 2021, 13 (02) : 1 - 20
  • [28] Prognostic significance of biomarker discordance after neoadjuvant chemotherapy in breast cancer
    Matsumoto, A.
    Jinno, H.
    Ando, T.
    Fujii, T.
    Nakamura, T.
    Saito, J.
    Takahashi, M.
    Hayashida, T.
    Kitagawa, Y.
    BREAST, 2015, 24 : S96 - S97
  • [29] Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
    Maria D Cao
    Guro F Giskeødegård
    Tone F Bathen
    Beathe Sitter
    Anna Bofin
    Per E Lønning
    Steinar Lundgren
    Ingrid S Gribbestad
    BMC Cancer, 12
  • [30] The Prognostic Value of Axillary Staging Following Neoadjuvant Chemotherapy in Inflammatory Breast Cancer
    Grova, Monica M.
    Strassle, Paula D.
    Navajas, Emma E.
    Gallagher, Kristalyn K.
    Ollila, David W.
    Downs-Canner, Stephanie M.
    Spanheimer, Philip M.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (04) : 2182 - 2190
12345